BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 30446221)

  • 1. Alleviation of fatty liver in a rat model by enhancing N
    Takeuchi K; Yokouchi C; Goto H; Umehara K; Yamada H; Ishii Y
    Biochem Biophys Res Commun; 2018 Dec; 507(1-4):203-210. PubMed ID: 30446221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of fatty liver in rats by nicotinamide via the regeneration of the methionine cycle and the inhibition of aldehyde oxidase.
    Yokouchi C; Nishimura Y; Goto H; Sato M; Hidoh Y; Takeuchi K; Ishii Y
    J Toxicol Sci; 2021; 46(1):31-42. PubMed ID: 33408299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential involvement of IL-6 in the early and late phase of 1-methylnicotinamide (MNA) release in Concanavalin A-induced hepatitis.
    Sternak M; Jakubowski A; Czarnowska E; Slominska EM; Smolenski RT; Szafarz M; Walczak M; Sitek B; Wojcik T; Jasztal A; Kaminski K; Chlopicki S
    Int Immunopharmacol; 2015 Sep; 28(1):105-14. PubMed ID: 25976094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of the nicotinamide N-methyltransferase (NNMT)-1-methylnicotinamide (MNA) pathway in pulmonary hypertension.
    Fedorowicz A; Mateuszuk Ł; Kopec G; Skórka T; Kutryb-Zając B; Zakrzewska A; Walczak M; Jakubowski A; Łomnicka M; Słomińska E; Chlopicki S
    Respir Res; 2016 Aug; 17(1):108. PubMed ID: 27581040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nicotinamide N-methyltransferase (NNMT) and 1-methylnicotinamide (MNA) in experimental hepatitis induced by concanavalin A in the mouse.
    Sternak M; Khomich TI; Jakubowski A; Szafarz M; Szczepański W; Białas M; Stojak M; Szymura-Oleksiak J; Chłopicki S
    Pharmacol Rep; 2010; 62(3):483-93. PubMed ID: 20631412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pan-caspase inhibitor VX-166 reduces fibrosis in an animal model of nonalcoholic steatohepatitis.
    Witek RP; Stone WC; Karaca FG; Syn WK; Pereira TA; Agboola KM; Omenetti A; Jung Y; Teaberry V; Choi SS; Guy CD; Pollard J; Charlton P; Diehl AM
    Hepatology; 2009 Nov; 50(5):1421-30. PubMed ID: 19676126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nicotinamide overload may play a role in the development of type 2 diabetes.
    Zhou SS; Li D; Sun WP; Guo M; Lun YZ; Zhou YM; Xiao FC; Jing LX; Sun SX; Zhang LB; Luo N; Bian FN; Zou W; Dong LB; Zhao ZG; Li SF; Gong XJ; Yu ZG; Sun CB; Zheng CL; Jiang DJ; Li ZN
    World J Gastroenterol; 2009 Dec; 15(45):5674-84. PubMed ID: 19960564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of nicotinamide N-methyltrasferase and increased formation of 1-methylnicotinamide (MNA) in atherosclerosis.
    Mateuszuk Ł; Khomich TI; Słomińska E; Gajda M; Wójcik L; Łomnicka M; Gwóźdź P; Chłopicki S
    Pharmacol Rep; 2009; 61(1):76-85. PubMed ID: 19307695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1-Methylnicotinamide ameliorates lipotoxicity-induced oxidative stress and cell death in kidney proximal tubular cells.
    Tanaka Y; Kume S; Araki H; Nakazawa J; Chin-Kanasaki M; Araki S; Nakagawa F; Koya D; Haneda M; Maegawa H; Uzu T
    Free Radic Biol Med; 2015 Dec; 89():831-41. PubMed ID: 26482866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developmental changes of aldehyde oxidase in postnatal rat liver.
    Tayama Y; Moriyasu A; Sugihara K; Ohta S; Kitamura S
    Drug Metab Pharmacokinet; 2007 Apr; 22(2):119-24. PubMed ID: 17495419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aldehyde oxidase-catalyzed metabolism of N1-methylnicotinamide in vivo and in vitro in chimeric mice with humanized liver.
    Kitamura S; Nitta K; Tayama Y; Tanoue C; Sugihara K; Inoue T; Horie T; Ohta S
    Drug Metab Dispos; 2008 Jul; 36(7):1202-5. PubMed ID: 18332084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single bout of endurance exercise increases NNMT activity in the liver and MNA concentration in plasma; the role of IL-6.
    Chłopicki S; Kurdziel M; Sternak M; Szafarz M; Szymura-Oleksiak J; Kamiński K; Żołądź JA
    Pharmacol Rep; 2012; 64(2):369-76. PubMed ID: 22661188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HPLC-UV method for measuring nicotinamide N-methyltransferase activity in biological samples: evidence for substrate inhibition kinetics.
    Patel M; Vasaya MM; Asker D; Parsons RB
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Mar; 921-922():87-95. PubMed ID: 23435346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of nicotinamide-N-methyltransferase mRNA expression in human adipose tissue and the plasma concentration of its product, 1-methylnicotinamide, with insulin resistance.
    Kannt A; Pfenninger A; Teichert L; Tönjes A; Dietrich A; Schön MR; Klöting N; Blüher M
    Diabetologia; 2015 Apr; 58(4):799-808. PubMed ID: 25596852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zebularine metabolism by aldehyde oxidase in hepatic cytosol from humans, monkeys, dogs, rats, and mice: influence of sex and inhibitors.
    Klecker RW; Cysyk RL; Collins JM
    Bioorg Med Chem; 2006 Jan; 14(1):62-6. PubMed ID: 16143537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxic effects of nicotinamide methylation on mouse brain striatum neuronal cells and its relation to manganese.
    Mori Y; Sugawara A; Tsuji M; Kakamu T; Tsuboi S; Kanda H; Hayakawa T; Fukushima T
    Environ Health Prev Med; 2012 Sep; 17(5):371-6. PubMed ID: 22249857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimation of aldehyde oxidase activity in vivo from conversion ratio of N1-methylnicotinamide to pyridones, and intraspecies variation of the enzyme activity in rats.
    Sugihara K; Tayama Y; Shimomiya K; Yoshimoto D; Ohta S; Kitamura S
    Drug Metab Dispos; 2006 Feb; 34(2):208-12. PubMed ID: 16299165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon-gamma elevates nicotinamide N-methyltransferase activity and nicotinamide level in human glioma cells.
    Yamada K; Miyazaki T; Hara N; Tsuchiya M
    J Nutr Sci Vitaminol (Tokyo); 2010; 56(2):83-6. PubMed ID: 20495288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NNMT activation can contribute to the development of fatty liver disease by modulating the NAD
    Komatsu M; Kanda T; Urai H; Kurokochi A; Kitahama R; Shigaki S; Ono T; Yukioka H; Hasegawa K; Tokuyama H; Kawabe H; Wakino S; Itoh H
    Sci Rep; 2018 Jun; 8(1):8637. PubMed ID: 29872122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potent Inhibition of Nicotinamide
    Gao Y; van Haren MJ; Buijs N; Innocenti P; Zhang Y; Sartini D; Campagna R; Emanuelli M; Parsons RB; Jespers W; Gutiérrez-de-Terán H; van Westen GJP; Martin NI
    J Med Chem; 2021 Sep; 64(17):12938-12963. PubMed ID: 34424711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.